Distinct capillary density and progression promoted by vascular endothelial growth factor-A homodimers and heterodimers

Angiogenesis

Volumn 1, Issue 1, 1997, Pages 117-130

  Morbidelli, Lucia ^a   Birkenhaeger, Ralf ^c,d   Roeckl, Wolfgang ^c   Granger, Harris J ^b   Kaerst, Uwe ^c   Weich, Herbert A ^c   Ziche, Marina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Capillary; Heterodimer; Homodimer; Vascular endothelial growth factor

Indexed keywords

EID: 0006702606     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018361217467     Document Type: Article

References (39)

1. Plouet J, Moukadiri H. Specific binding of vasculotropin to bovine brain capillary endothelial cells. Biochimie 1990; 72, 51-55.
2. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev 1997; 18, 4-25.
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267, 10931-10934.
4. Viglietto G, Maglione D, Rambaldi M, et al. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (P1GF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 1995; 11, 1569-1579.
5. Viglietto G, Romano A, Maglione D, et al. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta growth factor. Oncogene 1996; 13, 577-587.
6. Tisher E, Mitchel R, Hartman T, et al. The human gene for vascular endothelial growth factor. J Biol Chem 1991; 266, 11974-11984.
7. Maglione D, Guerriero V, Viglietto G, et al. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (P1GF), are transcribed from a single gene of chromosome 14. Oncogene 1993; 8, 925-931.
8. Connolly DT, Heuvelman D, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84, 1470-1478.
9. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161, 851-858.
10. 165 and PDGF-BB. Anat Embryol 1992; 186, 251-257.
11. Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219, 983-985.
12. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267, 26031-26037.
13. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor isoforms: differential deposition into the subepithelial matrix and bioactivity of ECM-bound VEGF. Mol Biol Cell 1993; 4, 1317-1326.
14. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin C-H. Different signal transduction properties of KDR and FLT1, two receptors for vascular endothelial growth factor. J Biol Chem 1996; 269, 26988-26995.
15. Park JE, Chen J, Winer J, Houck KA, Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to FLT-1 but not to FLK-1/KDR. J Biol Chem 1994; 269, 25646-25654.
16. Clauss M, Weich HA, Breier G, et al. The vascular endothelial growth factor receptor FLT-1 mediates biological activities. J Biol Chem 1996; 271, 17629-17634.
17. Barleon B, Sozzani S, Zhou F, Weich HA, Mantovani A, Marmé D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediates via the VEGF receptor flt-1. Blood 1996; 87, 3336-3343.
18. Birkenhaeger R, Schneppe B, Roeckl W, Wilting J, Weich HA, McCarthy J. Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor. Biochem J 1996; 316, 703-707.
19. Ziche M, Alessandri G, Gullino PM. Gangliosides promote the angiogenic response. Lab Invest 1989; 61, 629-634.
20. Ziche M, Morbidelli L, Masini E, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94, 2036-2044.
21. Schelling ME, Meininger CJ, Hawker JR, Granger HJ. Venular endothelial cells from bovine heart. Am J Physiol 1988; 254, H1211-1217.
22. Morbidelli L, Chang C-H, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates the mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996; 270, H411-415.
23. Ziche M, Morbidelli L, Geppetti P, Maggi C, Dolara P. Substance P induces migration of capillary endothelial cells: a novel NK-1 receptor mediated activity. Life Sci Pharmacol Lett 1991; 84, PL7-L11.
24. Taraboletti GD, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 1990; 111, 765-772.
25. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S. Identification of a c-fos-induced gene taht is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 1996; 93, 11675-11680.
26. Olofssson B, Pajusola K, von Euler G, Chilov D, Alitalo K, Eriksson U. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem 1996; 271, 19310-19317.
27. DiSalvo J, Bayne G, Conn PW, et al. Purification and characterization of a naturally occurring vascular endothelial growth factor:placenta growth factor heterodimer. J Biol Chem 1995; 270, 7717-7723.
28. Cao Y, Chen H, Zhou L, et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to FLK-1/KDR. J Biol Chem 1996; 271, 3154-3162.
29. Ziche M, Maglione D, Ribatti D, et al. Placenta growth factor-1 (P1GF-1) is chemotactic, mitogenic and angiogenic. Lab Invest 1997; in press.
30. Philips GD, Stone M, Jones BD, Schultz JC, Whitehead RA, Knighton DR. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. In vivo 1994; 8, 961-966.
31. Connolly DT, Heuvelmann DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84, 1470-1478.
32. Tessler S, Rockwell P, Hicklin D, et al. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem 1994; 269, 12456-12461.
33. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989; 86, 7311-7315.
34. 121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptor of human melanoma cells. J Biol Chem 1995; 270, 11322-11326.
35. 121) expressed in yeast. Biochem Biophys Res Commun 1995; 215, 750-756.
36. Keyt B, Berleau L, Nguyen H, et al. The carboxyl-terminal domain (111-165) of VEGF is critical for mitogenic potency. J Biol Chem 1996; 271, 7788-7795.
37. Wilting J, Christ B, Bokeloh M, Weich HA. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res 1993; 274, 163-172.
38. 121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of the chorioallantoic membrane. Dev Biol 1996; 176, 76-85.
39. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, Presta M. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 1995; 170, 39-49.